Category:EMA approved in 2018

From HemOnc.org - A Hematology Oncology Wiki

Jump to navigation Jump to search

Pages in category "EMA approved in 2018"

The following 10 pages are in this category, out of 10 total.

A

B

Binimetinib (Mektovi)

C

Cytarabine and daunorubicin liposomal (Vyxeos)

D

Durvalumab (Imfinzi)

E

Encorafenib (Braftovi)

M

Mogamulizumab (Poteligeo)

N

Neratinib (Nerlynx)

R

Retrieved from "https://hemonc.org/w/index.php?title=Category:EMA_approved_in_2018&oldid=53391"

EMA approved in the 2010s